Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

China SXT Pharmaceuticals, Inc. - Common Stock (NQ:SXTC)

2.830 +0.010 (+0.35%)
Streaming Delayed Price Updated: 9:52 AM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,690
Open 2.810
Bid (Size) 2.780 (100)
Ask (Size) 2.830 (100)
Prev. Close 2.820
Today's Range 2.780 - 2.880
52wk Range 0.0267 - 6.980
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Thursday's session: top gainers and losers ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill

Performance

YTD
+62.6%
+62.6%
1 Month
+67.5%
+67.5%
3 Month
+97.9%
+97.9%
6 Month
+79.1%
+79.1%
1 Year
+616.3%
+616.3%

More News

Read More
Monday's session: top gainers and losers ↗
Via Chartmill
Monday's session: gap up and gap down stocks ↗
Via Chartmill
Monday's pre-market session: top gainers and losers ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off? ↗
Via Stocktwits
Topics Artificial Intelligence Economy
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-01-28: top gainers and losers in today's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗
Via Chartmill
Gapping stocks in Wednesday's session ↗
Via Chartmill
Most active stocks in Tuesday's session ↗
Via Chartmill
The market is filled with gapping stocks in Tuesday's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
Which stocks have an unusual volume on Thursday? ↗
Via Chartmill
News headline image
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
From China SXT Pharmaceuticals, Inc.
Via GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
Monday's session: most active stocks ↗
Via Chartmill
These stocks have an unusual volume in today's session ↗
Via Chartmill

Frequently Asked Questions

Is China SXT Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, China SXT Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does China SXT Pharmaceuticals, Inc. - Common Stock trade on?
China SXT Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for China SXT Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for China SXT Pharmaceuticals, Inc. - Common Stock is SXTC on the Nasdaq Stock Market
What is the current price of China SXT Pharmaceuticals, Inc. - Common Stock?
The current price of China SXT Pharmaceuticals, Inc. - Common Stock is 2.830
When was China SXT Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of China SXT Pharmaceuticals, Inc. - Common Stock was at 02/06/26 09:52 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.